ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, and Advarra, the market leader in regulatory reviews ...
A Tucker man with Down syndrome is the only participant in a Vanderbilt clinical trial testing a potential treatment to lower ...
New research pits psychedelic-assisted therapy against traditional antidepressants in an unblinded study that presents a sobering viewpoint on the treatment's potential.
Clinical research organization Icon has entered into a partnership with research technology company Advarra to launch a ...
Study Will Investigate Pegevongitide's Ability to Prevent Acute Brain Injury in the Uniquely Vulnerable Hemodialysis Patient ...
A study found brain atrophy progresses more slowly with age in RRMS, highlighting the need to factor age into MS clinical ...
Hope Medicine Inc., a science-driven, clinical-stage innovative biopharmaceutical company, announced that the first patient ...
Bryan Adams, David Foster, and Others Unite for Fundraiser, with 100% of Money Raised Directly Funding Early-Phase ...
Dr. Richard Rovin, a neurosurgeon at Aurora St. Lukes Medical Center in Milwaukee came home from work in 2002 and his wife, a ...
The Mediterranean diet—rich in olive oil, fish, vegetables and legumes—has long been linked to better heart health. Growing ...
AEMD READ THE FULL AEMD RESEARCH REPORT DSMB recommends AEMD progress clinical trial to the final third cohort Aethlon Medical (NASDAQ: AEMD) announced today that the independent Data Safety ...